Liberate Bio
United States · $31.0M raised
- Employees
- 11–50
- Business Model
- B2B
- Website
- liberatebio.com
- Total Funding
- $31.0M
- Last Round
- $31.0M SeedOct 2025
- Rounds
- 1
About
Genetic medicines platform enabling in vivo reprogramming of disease-driving cells to cure disease.
Summary
Liberate Bio is a Biotech company based in United States. It has raised $31.0M in total across 1 round, most recently a $31.0M Seed round in Oct 2025. Investors include Khosla Ventures.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2025
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company